A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A CD40 targeting peptide prevents severe symptoms in experimental autoimmune encephalomyelitis

Published:2019-07 Issue: Volume:332 Page:8-15
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Vaitaitis Gisela M.,Yussman Martin G.,Wagner David H.

Funder

University of Colorado Cancer Center

Skin Diseases Research

National Institute of Allergy and Infectious Diseases

National Multiple Sclerosis Society

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference43 articles.

1. Visualisation of the kinetics of macrophage infiltration during experimental autoimmune encephalomyelitis by magnetic resonance imaging;Baeten;J. Neuroimmunol.,2008

2. Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction;Bajorath;Biochemistry,1995

3. Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis;Bajorath;Biochemistry,1995

4. CD40 on NOD CD4 T cells contributes to their activation and pathogenicity;Baker;J. Autoimmun.,2008

5. A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis;Boumpas;Arthritis Rheum.,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice;Cell Communication and Signaling;2023-11-09

2. Insights into CD154‐mediated pathways in ocular hypertensive glaucoma: The role of Müller cells and P2X7 in retinal neuroprotection and therapeutic potential;Cell Biology International;2023-05-03

3. Ocrevus reduces TH40 cells, a biomarker of systemic inflammation, in relapsing multiple sclerosis (RMS) and in progressive multiple sclerosis (PMS);Journal of Neuroimmunology;2023-01

4. The Search for Immunological Biomarkers in Type 1 Diabetes Mellitus (T1DM) and Multiple Sclerosis (MS): Th40 Cells Provide a Common Autoimmune Link;Biomarkers in Diabetes;2022-09-30

5. Emerging therapies to target CNS pathophysiology in multiple sclerosis;Nature Reviews Neurology;2022-06-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3